Research
OriginalInvestigation
Primary Results of the Patient-Centered Disease
Management (PCDM) for Heart Failure Study
A Randomized Clinical Trial
DavidB.Bekelman,MD,MPH;MaryE.Plomondon,PhD,MSPH;EvanP.Carey,MS;MarkD.Sullivan,MD,PhD;
KarinM.Nelson,MD,MSHS;BrackHattler,MD;ConnorF.McBryde,MD;KennethG.Lehmann,MD;
KatherineGianola,MD;PaulA.Heidenreich,MD;JohnS.Rumsfeld,MD,PhD
Supplementalcontentat
IMPORTANCEHeartfailure(HF)hasamajoreffectonpatients’healthstatus,includingtheir jamainternalmedicine.com
symptomburden,functionalstatus,andhealth-relatedqualityoflife.
OBJECTIVE Todeterminetheeffectivenessofacollaborativecarepatient-centereddisease
management(PCDM)interventiontoimprovethehealthstatusofpatientswithHF.
DESIGN,SETTING,ANDPARTICIPANTS ThePatient-CenteredDiseaseManagement(PCDM)
trialwasamultisiterandomizedclinicaltrialcomparingacollaborativecarePCDM
interventionwithusualcareinpatientswithHF.Apopulation-basedsampleof392patients
withanHFdiagnosisfrom4VeteransAffairscenterswhohadaKansasCityCardiomyopathy
Questionnaire(KCCQ)overallsummaryscoreoflessthan60(heavysymptomburdenand
impairedfunctionalstatusandqualityoflife)wereenrolledbetweenMay2009andJune2011.
INTERVENTIONS ThePCDMinterventionincludedcollaborativecarebyamultidisciplinary
careteamconsistingofanursecoordinator,cardiologist,psychiatrist,andprimarycare
physician;hometelemonitoringandpatientself-managementsupport;andscreeningand
treatmentforcomorbiddepression.
MAINOUTCOMESANDMEASURES TheprimaryoutcomewaschangeintheKCCQoverall
summaryscoreat1year(a5-pointchangeisclinicallysignificant).Mortality,hospitalization,
anddepressivesymptoms(PatientHealthQuestionnaire9)weresecondaryoutcomes.
RESULTS Therewerenosignificantdifferencesinbaselinecharacteristicsbetweenpatients
randomizedtothePCDMintervention(n=187)vsusualcare(n=197);baselinemeanKCCQ
overallsummaryscoreswere37.9vs36.9(P=.48).Therewassignificantimprovementinthe
KCCQoverallsummaryscoresinbothgroupsafter1year(meanchange,13.5pointsineach
group),withnosignificantdifferencebetweengroups(P=.97).Theinterventionwasnot
associatedwithgreaterimprovementintheKCCQoverallsummaryscoreswhentheeffect
overtimewasestimatedusing3-month,6-month,and12-monthdata(P=.74).Among
secondaryoutcomes,thereweresignificantlyfewerdeathsat1yearintheinterventionarm
(8of187[4.3%])thanintheusualcarearm(19of197[9.6%])(P=.04).Amongthosewho
screenedpositivefordepression,therewasagreaterimprovementinthePatientHealth
Questionnaire9scoresafter1yearintheinterventionarmthanintheusualcarearm(2.1
pointslower,P=.01).Therewasnosignificantdifferencein1-yearhospitalizationrates
betweentheinterventionarmandtheusualcarearm(29.4%vs29.9%,P=.87).
CONCLUSIONSANDRELEVANCE ThismultisiterandomizedtrialofamultifacetedHFPCDM AuthorAffiliations:Author
interventiondidnotdemonstrateimprovedpatienthealthstatuscomparedwithusualcare. affiliationsarelistedattheendofthis
article.
CorrespondingAuthor:DavidB.
TRIALREGISTRATION clinicaltrials.govIdentifier:NCT00461513
Bekelman,MD,MPH,Research(151),
VeteransAffairsEasternColorado
HealthCareSystem,1055Clermont
JAMAInternMed.2015;175(5):725-732.doi:10.1001/jamainternmed.2015.0315 St,Denver,CO80220
PublishedonlineMarch30,2015. (david.bekelman@va.gov).
(Reprinted) 725
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Rutgers University Libraries User on 06/01/2015
Research OriginalInvestigation Patient-CenteredDiseaseManagementforHeartFailureTrial
H
eartfailure(HF)remainsaleadingcauseofdisability, tronichealthrecordwerescreenedforeligibilitytopartici-
hospitalization,anddeathintheVeteransAffairs(VA) pate.Followingpreviouslydescribedcasefindingmethods,19
systemandtheUnitedStatesasawhole.1,2Ithasama- thestudywasdesignedtotargetallpatientswithadiagnosis
joreffectonpatients’healthstatus,definedastheirsymp- ofHF,irrespectiveofthetypeofHF(eg,includingthosewith
tomburden,functionalstatus,andhealth-relatedqualityof andwithoutpreservedleftventricularsystolicfunction).There-
life.Todate,fewHFinterventionshavespecificallytargeted fore,thediagnosisofHFwasdefinedasmeetingany1ofthe
thesecriticalpatient-centeredoutcomes.2-4 following5criteria:(1)aprimaryinpatienthospitaldischarge
Diseasemanagement,variouslydefined,5hasbeenpro- diagnosisofHF(InternationalClassificationofDiseases,Ninth
motedasastrategytoimproveoutcomesofpatientswithHF. Revision[ICD-9]code428.XX);(2)atleast2secondaryinpa-
Itusuallyreferstomultidisciplinaryeffortstoimprovethequal- tienthospitaldischargediagnosesofHF(ICD-9codes428.XX)
ityandcost-effectivenessofcareforselectedpatientswith andaprimaryinpatienthospitaldischargediagnosisrelated
chronicconditions.Theseprogramsinvolveinterventionsde- toheartdisease(ICD-9codes410.XX,412.XX,413.XX,and
signedtoimproveadherencetoscientificguidelinesandtreat- 414.XX);(3)atleast3secondaryinpatienthospitaldischarge
mentplans.6However,theassociationbetweenHFdisease diagnosiscodesrelatedtoHF;(4)atleast2outpatientvisitdi-
managementandoutcomesisinconsistent.4,7-12Heartfailure agnosesofHF,excludingemergencydepartmentvisits;and
diseasemanagementinterventionshaveoftenreliedsolelyon (5)atleast2secondaryinpatienthospitaldischargediagno-
nursecasemanagement. sesofHFandatleast1outpatientHFdiagnosis.19
WedevelopedthePatient-CenteredDiseaseManage- PotentiallyeligiblepatientswerescreenedwiththeKan-
ment(PCDM)interventiontoaddresstheseshortcomingsby sasCityCardiomyopathyQuestionnaire(KCCQ)toidentifypa-
combiningmultidisciplinarycollaborativecare,hometelem- tientswithadiagnosisofHFandreducedhealthstatus.Indi-
onitoring,anddepressionmanagement.Multidisciplinarycol- vidualsscoringlessthan60ontheKCCQoverallsummaryscore
laborativecarehasbeenshowntobeeffectiveindiabetesmelli- (indicatingsignificantHFsymptoms,limitedfunctionalsta-
tus,hypertension,lipidlevel,anddepressionmanagement.13,14 tus,andpoorqualityoflife)wereinvitedtoanenrollmentvisit
Hometelemonitoringinisolationhasnotimprovedoutcomes.15 iftheydidnothaveanyexclusioncriteria.Exclusioncriteria
However,integratinghometelemonitoringwithmultidisci- were(1)severecognitiveorpsychiatricimpairment;(2)cur-
plinarycollaborativecareteammanagementmayimproveout- rentresidenceinanursinghome;(3)irreversible,noncardiac
comesthroughtheprovisionofactionable,guideline-based medicalconditionslikelytoaffect6-monthsurvivalorability
treatmentrecommendationstailoredtoindividualpatients.To toexecutethestudyprotocol(eg,metastaticcancer);(4)prior
date,nostudieshavetargetedimprovingpatienthealthsta- hearttransplantation;and(5)alcoholabuseasindicatedbythe
tusasaprimaryoutcomeoraddressedkeybarrierssuchasco- AlcoholUseDisordersIdentificationTest20scoreofatleast7.
morbiddepression.Itisimportanttoassessandmanagede- Atenrollment,eligiblepatientsprovidedwrittenin-
pressioninHFbecausedepressionisassociatedwithpoor formedconsent,completedbaselinesurveymeasures,and
treatmentadherence,healthstatus,andotheroutcomes.4,16,17 werethenrandomizedtothePCDMinterventionortousual
Finally,toourknowledge,theeffectivenessofdiseaseman- care.Thestudydatabasewasusedtocreatetherandomiza-
agementforHFhasnotpreviouslybeenevaluatedintheDe- tionsequenceusingblockrandomization,withstratification
partmentofVeteransAffairs,thelargestintegratedhealthcare bystudysiteand1:1randomizationofpatientstotheinter-
systemintheUnitedStates. ventionandtousualcare.Therandomizationsequencewas
ThemultisitePCDMtrialevaluatedthecombinationof concealedfromthestudypersonnel.Randomizationoc-
multidisciplinarycollaborativecare,telemonitoring,andjoint curredafterbaselinesurveyinformationwasenteredintothe
HFanddepressionmanagement.Theprimaryaimwastode- database.Thestudywasapprovedbytheinstitutionalre-
terminewhethertheinterventionresultedinbetterpatient viewboardsateachofthestudysites.Thefullstudyprotocol
healthstatus(ie,symptomburden,functionalstatus,andqual- canbefoundinthetrialprotocolintheSupplement.
ityoflife)thanusualcare.Thesecondaryaimsweretodeter-
minewhetherthediseasemanagementinterventionre- PCDMIntervention
sultedinreducedhospitalizations,depressivesymptoms,or Theinterventionincluded3components.Theseweremulti-
mortality. disciplinarycollaborativecareHFdiseasemanagement,screen-
ingforandtreatmentofdepression,andtelemonitoringwith
patientself-caresupport.
Methods
CollaborativeCare
SettingandPopulation Eachsitehadacollaborativecareteamconsistingofanurse
The methods of the PCDM trial have been previously coordinator(registerednurse),aprimarycarephysician,a
described.18ThestudywasconductedattheVAmedicalcen- cardiologist,andapsychiatrist.Foreachinterventionpatient,
tersinDenver,Colorado,PaloAlto,California,Richmond,Vir- theteamreviewedtheelectronichealthrecordandbaseline
ginia,andSeattle,Washington,aswellasattheiraffiliatedcom- depressionscoresfromthePatientHealthQuestionnaire9
munity-basedoutpatientclinics.Allpatientswithanassigned (PHQ-9).Theteamrecommendedcarechangesforagiven
VAprimarycarephysicianandatleast1primarycarevisitdur- patientinaccordwiththeAmericanCollegeofCardiology
ingtheprior12monthswithaHFdiagnosiscodeintheVAelec- andAmericanHeartAssociationGuidelinesfortheDiagnosis
726 JAMAInternalMedicine May2015 Volume175,Number5 (Reprinted) jamainternalmedicine.com
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Rutgers University Libraries User on 06/01/2015
Patient-CenteredDiseaseManagementforHeartFailureTrial OriginalInvestigation Research
andManagementofHeartFailureinAdults21andthecollab- UsualCare
orativedepressioncareinterventionasdescribedherein.In Patientsrandomizedtotheusualcarearmcontinuedtore-
addition,theteammetweeklytorecommendcarechanges ceivecarefromtheirregularhealthcareprofessionalsandregu-
basedonreviewoftelemonitoringdataandthefollow-up lartelehealthnurses(ifenrolledintelemonitoring),withno
PHQ-9scores.Collaborativecareteamrecommendations involvementofthestudycollaborativecareteam.Carewas
wereenteredintoaprogressnoteandwrittenasunsigned fullyatthediscretionofthepatient’sregularhealthcarepro-
ordersintheelectronicmedicalrecordforreviewandsigna- fessionalsandmayormaynothaveincludedcardiologyor
turebythepatient’sprimarycarephysician.Thismethod mentalhealthcliniccareinadditiontoprimarycare.Usualcare
wassuccessfullyusedinapriorVAinterventionstudy22for patientsweregiveninformationsheetsattheenrollmentvisit
angina,withahighrateofacceptanceoftherecommenda- thatdescribedself-careforHFandwereprovidedwithaweigh-
tionsbyVAprimarycarephysicians. ingscaleifneeded.Primarycarephysicianswerenotifiedif
usualcarepatientsscreenedpositivefordepressivesymp-
ScreeningandTreatmentofDepression tomsbasedontheinitialstudysurveys.Fromthenon,pa-
Interventionpatientswhoscreenedpositivefordepression tients’primarycarephysiciansassumedresponsibilityforde-
(PHQ-9score,≥10)receivedthedepressioncarecomponent pressioncare.
oftheintervention,adaptedfromasuccessfulcollaborative
depressioncareintervention.23Thisincluded(1)upto11ses- OutcomeMeasures
sionsofbehavioralactivationandantidepressantmanage- Theprimaryoutcome,patient-reportedHF-specifichealthsta-
ment,providedbythenursecoordinatorandsupervisedby tus,wasmeasuredusingtheKCCQ.Thisquestionnaireisvalid,
theteampsychiatrist;(2)adepressioneducationalvideo; reliable,andsensitivetoclinicalchangeandpredictshospital-
and(3)depressionassessmentandself-managementeduca- izationandmortality.24-26Forthesecondarymeasures,depres-
tionviatelemonitoring.Beforeenrollmentbegan,thenurse sionwasmeasuredusingthePHQ-9.Thisquestionnaireisavalid
coordinatorfromeachsiteparticipatedina2-daytrainingon andreliableinstrumentthatprovidesacontinuousmeasureof
depressionandbehavioralactivationbytheleadstudypsy- depressivesymptoms.27Baselinesurveymeasureswerecol-
chiatrist(M.D.S.)and4weeklyfollow-upcallswiththelead lectedinperson.Aresearchassistant(whowasblindedtothe
studypsychiatrist.Thereafter,thenursewassupervisedby randomizationarm)collected3-monthand6-monthfollow-up
thesitepsychiatristviaas-neededcallswiththeleadpsy- studyoutcomemeasuresbyphoneorinperson.Thenurseco-
chiatristandDrBekelman.Thedepressioncarecomponent ordinatorcollectedmeasuresat12monthsbyphoneorinper-
ofthenurseinterventionwasstandardizedinatreatment son.MortalityandhospitalizationswereassessedthroughVA
manualthatdescribeddetailedproceduresforwhattodis- databases,supplementedbypatientself-report.Vitalstatuswas
cusswithpatients. alsoascertainedviatheVAVitalStatusFile,whichhasasen-
sitivityof98.3%andaspecificityof99.8%comparedwiththe
TelehealthTelemonitoringandPatientSelf-careSupport NationalDeathIndex.28
Interventionpatientsreceiveddailytelemonitoringusing
home-basedequipmentthattrackedsignsandsymptomsof SampleSizeandEnrollmentTargets
HFanddepression.Thesystemcollecteddailymeasuresof Theprimaryhypothesisofthisstudywasthatpatientswith
bloodpressure,pulse,weight,andself-reportedsymptoms(eg, HFreceivingthePCDMinterventionwouldhavegreaterim-
shortnessofbreathandedema).Patientswithdepressionwere provementinhealthstatusovera12-monthfollow-upperiod
askedquestionsabouttheirmoodandbehavior.Thetelem- comparedwiththosereceivingusualcare.Theminimalclini-
onitoringsystemassignedarisktoeachresponseonthesys- callymeaningfuldifferenceintheKCCQoverallsummary
tem.Thenursereviewedmediumriskindicatorsandde- scoresis5points,26andtheSDofchangeintheKCCQoverall
cidedwhetheranactionneededtobetaken(eg,forpatients summaryscoreswasestimatedtobe15to20pointsbasedon
unabletounderstandalowsodiumdiet,thenurseprovided previouswork.25,26Withanestimatedattritionrateof30%,we
counseling).Thenurseactedonallofthehighriskindicators originallyestimatedthatenrollmentof600patientswould
bycontactingthepatientforassessmentandthen,ifneces- yieldgreaterthan80%powertodetectadifferenceintheKCCQ
sary,contactedthecareteamforanychangesinmedications overallsummaryscoresofatleast5points,assuminganSDof
orteststobewrittenintheelectronicmedicalrecord.Forex- 18.Alowerthanexpectedenrollmentwaspartiallyoffsetbya
ample,thecollaborativecareteamcouldsetandchangeanin- greaterthanexpectedretentionrate(attrition,<20%).The
dividualpatient’sdryweightandrecommendadiureticdos- KCCQSDwas15points.Hence,thestudyrecruitmentcon-
ingguidelinetoprimarycarephysicians. cludedwithenrollmentof392patients,withanestimated
Theself-careprogramsincludedmedicationremindersto greaterthan80%powertodetecta5-pointdifferenceinthe
promoteadherence,educationaboutHFanddepression,medi- KCCQoverallsummaryscoresbetweengroups.
cationmonitoring,anddietaryadvice.Patientsweretaughtthe
importanceofdailyself-weighing,adherencetoalowso- StatisticalAnalysis
diumdietandmedicationregimens,andrecognitionofearly Allprimaryandsecondaryanalyseswereconductedusingan
signsandsymptomsofHFdecompensation.Adherenceof intent-to-treatapproach.Baselinecharacteristicsofpatients
nursesandthecollaborativecareteamtothestudyprotocol wereassessedbystudygroupusingttestsforcontinuousvari-
wasnotformallymeasured. ablesandχ2testsforcategoricalvariables.Fortheprimaryout-
jamainternalmedicine.com (Reprinted) JAMAInternalMedicine May2015 Volume175,Number5 727
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Rutgers University Libraries User on 06/01/2015
Research OriginalInvestigation Patient-CenteredDiseaseManagementforHeartFailureTrial
paredbetweenstudyarmsusingaχ2ttest.Log-ranktestswere
Figure1.ConsolidatedStandardsofReportingTrialsDiagram
usedtoanalyzetimetodeathandtimetohospitalization.
ofthePCDMforHFTrial
7783Assessed for eligibility
Results
3981Excluded
2097Unable to contact Intotal,392patientswererandomizedbetweenMay2009and
1884Declined to participate June2011(Figure1).Thestudypopulationwasmostlymale
(96.6%)andofwhiterace/ethnicity(81.8%),withameanage
3410Ineligible of68years,typicaloftheUSveteranpopulation(Table1).Par-
3023Not meeting inclusion
criteria ticipantshadcomorbiditiescommoninHF,includingdiabe-
387Deemed ineligible by tesmellitus(50.0%),priormyocardialinfarction(40.6%),
primary care physician
chronicobstructivepulmonarydisease(30.2%),andobstruc-
tivesleepapnea(43.8%).Thirty-eightpercenthadejectionfrac-
392Randomized
tionoflessthan40%.Atbaseline,themeanKCCQoverallsum-
maryscoreswere37.9intheinterventiongroupand36.9inthe
193Allocated to PCDM 199Allocated to usual
intervention arm care arm usualcaregroup(P=.48),indicatinghighsymptomburden
187Received PCDM 197Received usual care andpoorfunctionalstatusandqualityoflife.Follow-uprates
intervention 2Dropout after
6Dropout after randomization weregood,withprimaryoutcomeassessmentscompletedin
randomization 89.8%(352of392)ofparticipantsatmonth3,in84.4%(331of
392)ofparticipantsatmonth6,andin86.0%(337of392)of
3-mo Follow-up 3-mo Follow-up participantsatmonth12.
172Assessed 180Assessed
21Unable to contact 19Unable to contact TheindividualpatientKCCQoverallsummaryscoretra-
7Dropout 8Dropout jectoriesforpatientsintheinterventionandusualcarearms
13Cumulative dropouts 10Cumulative dropouts
overthestudyperiodareshowninFigure2.After1year,the
meanKCCQoverallsummaryscorehadincreasedby13.5
6-mo Follow-up 6-mo Follow-up pointsforboththeinterventionandcontrolgroups(P=.97).
164Assessed 167Assessed
29Unable to contact 32Unable to contact Theinterventionwasnotassociatedwithgreaterimprove-
5Dropout 7Dropout mentintheKCCQoverallsummaryscoreswhentheeffect
18Cumulative dropouts 17Cumulative dropouts
overtimewasestimatedusingthe3-month,6-month,and
12-monthdata(P=.74).Model-estimatedKCCQoverallsum-
12-mo Follow-up 12-mo Follow-up maryscoresintheinterventionandusualcarearms,respec-
165Assessed 172Assessed
28Unable to contact 27Unable to contact tively,were43.8(95%CI,42.3-45.4)and43.7(95%CI,42.1-
10Dropout 9Dropout
45.2)at90days,47.2(95%CI,45.5-48.9)and46.9(95%CI,
28Cumulative dropouts 26Cumulative dropouts
45.2-48.6)at180days,and54.2(95%CI,51.7-56.6)and53.6
(95% CI, 51.1-56.0) at 365 days. There were no harmful
187Analyzed 197Analyzed
6Excluded from 2Excluded from adverseeventsattributedtotheintervention.
analysis (dropped out analysis (dropped out Amongsecondaryoutcomes,thereweresignificantlyfewer
at randomization) at randomization)
deathsat1yearintheinterventionarm(8of187[4.3%])than
intheusualcarearm(19of197[9.6%])(P=.04);thenumber
HFindicatesheartfailure;PCDM,patient-centereddiseasemanagement. neededtotreatwas20(95%CI,10-307).Fewerpatientsdied
intheinterventionarmovertime(P=.04,log-ranktest).There
wasnosignificantdifferencein1-yearhospitalizationratesbe-
come,changeintheKCCQoverallsummaryscoresfrombase- tweentheinterventionarmandtheusualcarearm(29.4%vs
lineto1yearbetweentheinterventionandusualcaregroups 29.9%,P=.87)orintimetohospitalizationbetweengroups.
amongpatientswhohadbothbaselineand1-yearKCCQover- Amongthosewhoscreenedpositivefordepression,therewas
allsummaryscoreswascomparedusingapairedttest.Inad- greaterimprovementinthePHQ-9scoreafter1yearinthein-
dition,alikelihood-basedrandom-effectsmodelwasper- terventionarmthanintheusualcarearm(2.1;95%CI,0.43-
formedtocomparechangeintheKCCQoverallsummaryscores 3.78pointslower;P=.01).Oftherecommendationsmadeby
overtimebetweenarmstoaccountformissingdataandlon- thecollaborativecareteams,75.7%wereacceptedbypri-
gitudinaltrends.29Themagnitudeandpatternsofmissingdata marycarephysicians(Table2).
wereanalyzedtoconfirmthevalidityofmodelassumptions.
ModelparameterswereestimatedusingtheMIXEDproce-
dure(SAS,version9.3;SASInstituteInc).Changesindepres-
Discussion
sivesymptoms(PHQ-9scores)wereanalyzedamongpatients
whoscreenedpositivefordepression(PHQ-9score,≥10)using Inthismultisiterandomizedclinicaltrialof392patientswith
thesamemixedmodelingapproach.Thenumbersofall- HFandpoorhealthstatus,wefoundthatthemultifaceted
causehospitalizationsanddeathsat12monthswerecom- PCDMinterventiondidnotsignificantlyimprovetheprimary
728 JAMAInternalMedicine May2015 Volume175,Number5 (Reprinted) jamainternalmedicine.com
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Rutgers University Libraries User on 06/01/2015
Patient-CenteredDiseaseManagementforHeartFailureTrial OriginalInvestigation Research
Table1.BaselineCharacteristicsof384ParticipantsEnrolledinthePatient-CenteredHeartFailureTriala
InterventionArm UsualCareArm
Characteristic (n=187) (n=197)
Demographics
Age,mean(SD),y 67.3(9.6) 67.9(10.6)
Malesex,No.(%) 178(95.2) 193(98.0)
Whiterace/ethnicity,No.(%) 149(79.7) 165(83.8)
MedicalHistory,No.(%)
Myocardialinfarction 71(38.0) 85(43.1)
Percutaneouscoronaryintervention 31(16.6) 48(24.4)
Coronaryarterybypassgraft 44(23.5) 64(32.5)
Atrialfibrillation 73(39.0) 70(35.5)
Implantablecardiacdefibrillator 37(19.8) 42(21.3)
Biventricularpacemaker 7(3.7) 14(7.1)
Otherpacemaker 21(11.2) 26(13.2)
Diabetesmellitus 99(52.9) 93(47.2)
Hypertension 158(84.5) 159(80.7)
Chronicobstructivepulmonarydisease 57(30.5) 59(29.9)
Obstructivesleepapnea 85(45.5) 83(42.1)
Peripheralvasculardisease 22(11.8) 26(13.2)
HeartFailureCharacteristics
Nonischemicetiology,No.(%) 97(51.9) 96(48.7)
Leftventricularejectionfraction,No.(%)b
Normal 78(45.6) 84(47.5)
Mildlyreduced 34(19.9) 34(19.2)
Moderatelyreduced 46(26.9) 32(18.1)
Severelyreduced 13(7.6) 27(15.3)
NewYorkHeartAssociationclassification,No.(%)c
1 16(8.9) 16(8.5)
2 77(42.8) 85(45.0) Abbreviation:IQR,interquartile
range.
3 82(45.6) 82(43.4)
aTherewerenostatistically
4 5(2.8) 6(3.2) significantdifferencesbetween
6-minWalk,median(IQR),yd 765(510-1125) 822(356-1140) groupsatbaseline.
Medications,No.(%) bLeftventricularejectionfraction
wasavailableforonly177usualcare
Angiotensin-convertingenzymeinhibitororangiotensinreceptorblocker 122(65.2) 117(59.4)
patientsand171intervention
β-Blocker 132(70.6) 129(65.5) patients.Normalisatleast50%,
Eplerenone 5(2.7) 5(2.5) mildlyreducedis40%to49%,
moderatelyreducedis30%to
Spironolactone 49(26.2) 46(23.4)
39%,andseverelyreducedisless
HealthStatusandDepression than30%.
KansasCityCardiomyopathyQuestionnairescore,mean(SD) 37.9(13.3) 36.9(14.6) cNewYorkHeartAssociation
Positivedepressionscreen,No.(%) 78(41.7) 77(39.1) classificationwasavailableforonly
189usualcarepatientsand180
PatientHealthQuestionnaire9score,median(IQR) 9(4-13) 8(4-11)
interventionpatients.
outcomeofpatient-reportedhealthstatusinHFcomparedwith toring.Priorstudies30-41evaluatingtheeffectofHFdisease
usualcare.Patienthealthstatussignificantlyimprovedover managementprogramsonhealthstatusorqualityoflifehave
timeinboththeinterventionandusualcarecohorts.Among yieldedmixedresults,andhealthstatuswasoftenasecond-
secondaryoutcomes,therewerefewerdeathsamongthein- aryoutcome.WhilewecannotdeterminewhythePCDMin-
terventiongroupandreduceddepressivesymptomsamong terventionwasunsuccessfulinimprovingpatienthealthsta-
thosewhoscreenedpositivefordepression.WiththePCDM tuscomparedwithusualcare,severalreasonsarepossible.
intervention,nodifferenceswereobservedinhospitaliza- First,theinterventionmaysimplynotbeeffectiveagainstthe
tionrates. backgroundofcurrentusual,orstandard,HFcareintheVA
ThePCDMinterventionwasuniqueamongdiseaseman- system.Second,whiletheinterventionwasstructuredand
agementinterventionsbecauseofitsprimaryoutcomefocus fullyspecifiedforimplementation,itwasnotpossibletoguar-
onpatienthealthstatusandbecauseitaddeddepressioncare anteestrictimplementationofallcomponents.Forexample,
toothertypicaldiseasemanagementcomponentsandused wedidnotaudiorecordandreviewthenursecounselingses-
multidisciplinarycollaborativecarecombinedwithtelemoni- sionsforfidelitytotheintervention.Whilemanyofthecol-
jamainternalmedicine.com (Reprinted) JAMAInternalMedicine May2015 Volume175,Number5 729
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Rutgers University Libraries User on 06/01/2015
Figure2.KansasCityCardiomyopathyQuestionnaireScores
OvertheStudyPeriodintheInterventionandUsualCareArms
100
75
50
25
theoriginalstudiesweresmall,single-centertrials.42,43Dis-
easemanagementinterventionsareheterogeneousand
0 complex,anditcanbedifficulttodistinguishtheeffectof
0 180 365 500 interventioncomponentsfromtheeffectoftheskilledand
motivatedstaffwhoconducttheintervention.Telemonitor-
ing,akeycomponentofmanyHFdiseasemanagement
interventions,wasshownina2010study15tobeineffective,
contradictingthefindingsofapriormeta-analysis.Itmaybe
thatdifferentdiseasemanagementcomponentsareneeded
fordifferentoutcomes(eg,healthstatus,hospitalization,
andmortality).
Thereductioninmortalityassociatedwiththeintervention
has been found in other studies of disease management
interventions.43However,becausemortalitywasasecondary
outcomeherein,webelievethatitwouldbeinappropriateto
inferthatthePCDMinterventionledtoreducedmortality.
Rather,weviewthisfindingashypothesisgenerating,imply-
ingtheneedforfuturestudiesadequatelypoweredtodetect
adifferenceinmortalityasaprimaryoutcome.
Theimprovementinhealthstatusinbotharmsofthe
trialhassomeimplications.First,thisfindingshowsthe
importanceofexaminingtheefficacyofdiseasemanagement
interventionsusingarandomizedstudydesign.Evaluating
thisinterventionusingapre-poststudydesignwouldhave
laborativecareteamrecommendationswereaccepted,some foundanimprovementinhealthstatusmorethantwicethe
werenot,andthismayhavelimitedtheeffectivenessofthe minimalclinicallymeaningfulchange,thesameimprove-
intervention.Third,becauseseveralrecommendationswere mentobservedintheusualcarearm.Second,itunderscores
forconsultationsanddiagnostictesting,itmaytakelongerthan challengesinstudyingapopulationwithpoorhealthstatus
the1-yearstudyperiodtoseechangesinhealthstatus.Fourth, becausesomeoftheimprovementinhealthstatusinboth
whilethedepressioninterventionresultedinanimprove- armsmayhavebeenduetonaturalvarianceorregressionto
mentindepressivesymptoms,theimprovementmayhave themean.
beentoosmalltoimprovethehealthstatus.Animprovement Thereareseverallimitationstothisstudy.Wewereun-
of2.1pointsinthePHQ-9scoreisbelowtheminimallyimpor- abletoblindparticipantstotheintervention.Becausethestudy
tantdifferenceof5points.Futurestudiesofdiseasemanage- wasconductedamongthepopulationofUSveterans,there-
mentinterventionscouldconsideradditionalimplementa- sultsmaynotbegeneralizabletootherhealthsystemsand
tionprocessdatatocaptureaspectsofimplementationsuch populations.Additionaldataonaspectsofimplementationof
asthenumberandqualityofcontactswiththecarecoordina- theinterventionmayhaveinformedwhytheinterventiondid
tor,physiologicalmonitoring,medicationadherence,orself- notimprovehealthstatuscomparedwithusualcare.
management.
Thisstudyraisesquestionsabouttheeffectivenessand
cost-effectivenessofdiseasemanagementinterventions
Conclusions
inthecurrenthealthcareenvironment.Whilesystematic
reviewsandmeta-analyseshaveshownreducedhospitaliza- In conclusion, the multifaceted PCDM intervention for
tionsandoccasionallyreducedmortalityfromdiseaseman- patientswithHFdidnotimproveHFhealthstatuscompared
agement,thereisheterogeneityintheresults,andmanyof withusualcare.Thisstudyaddstotheexistingliteratureby
Copyright 2015 American Medical Association. All rights reserved.
eriannoitseuQ
yhtapoymoidraC
ytiC
sasnaK
erocS
yrammuS
llarevO
Intervention Arm
90
Time, d
100
75
50
25
0
0 180 365 500
eriannoitseuQ
yhtapoymoidraC
ytiC
sasnaK
erocS
yrammuS
llarevO
Research OriginalInvestigation Patient-CenteredDiseaseManagementforHeartFailureTrial
Table2.ImplementationofCollaborativeCareTeamRecommendations
intheInterventionArm
Accepted
Total Recommendations,
TypeofRecommendation Recommendations No.(%)
Medication 286 215(75.2)
Consult,suchasphysical 116 86(74.1)
therapy,medicalspecialty
Laboratorytest 69 59(85.5)
Othertest,suchasimaging 40 27(67.5)
Total 511 387(75.7)
Usual Care Arm
90
Time, d
Shownareindividualpatienttrajectories.Thedarkenedlinesshowthemean
KCCQovertimeusinglocallyweightedscatterplotsmoothing.
730 JAMAInternalMedicine May2015 Volume175,Number5 (Reprinted) jamainternalmedicine.com
Copyright 2015 American Medical Association. All rights reserved.
Downloaded From: http://archinte.jamanetwork.com/ by a Rutgers University Libraries User on 06/01/2015
Patient-CenteredDiseaseManagementforHeartFailureTrial OriginalInvestigation Research
leavingopenquestionsabouttheeffectivenessandcost- ingmaymeritfurtherstudyinanotherinvestigation.While
effectivenessofdiseasemanagementandtelemonitoring thereissignificantenthusiasmfordiseasemanagementpro-
interventions for patients with HF. Fewer deaths were gramsinHF,rigorousevaluationoftheseprogramscontin-
observedintheinterventionarmofthistrial,andthisfind- uestobenecessary.
ARTICLEINFORMATION REFERENCES 13.KatonW,RussoJ,LinEH,etal.
AcceptedforPublication:January26,2015. 1.AshtonCM,BozkurtB,ColucciWB,etal. Cost-effectivenessofamulticonditioncollaborative
P dou ib :1l 0is .h 10e 0d 1O /jan mlin ae in: tM era nrc mh e3 d0 .2, 020 151 .5 0.
315.
V Ine itt ie ar ta ivn es iA nf cfa hi rr os nQ icua hl eit ay rtE fn ah ila un rece .Mm ee dnt CR ae res .e 2a 0rc 0h
0;
c Aa rr ce hi Gn ete nr Pve syn ct hio ian t: ra y.ra 2n 0d 1o 2;m 6i 9z (e 5d ):c 5o 0n 6tr -o 51ll 4e .dtrial.
38(6)(suppl1):I26-I37. 14.GilbodyS,BowerP,FletcherJ,RichardsD,
A A E ( RBa umu es mt t kbh e e suo r fll n m er a ltA C dao no )f r ;f y ,li o DPl Ci r ea la oa pt dr mi aeo o r, on tHa n ms n e d: ed aR o nle t nC ths ,a oe CCr fa d aar Mi rroc eeh el yo S d, ,gG y iH cy se i, at nr V e ti eta me l ,et t Ur ,e ri ,Dc nr Mas e ivn, n c es Bv rA e sry irf tf d ya ei or ,s
f
2 R h In. ee taa eK rd rr t nmu f Mm ais il eh s u dio ro .el nz 1a 9H a m 9fM t 7oe ;, n 1rP 5gh 7a o M (r 1se )epn :d 9it t i 9aE cl a -M i 1z r 0ea, tT 4biu o .enN nef, o fe ir ct c ia aol r. n ieg se .s Ati rv ce h (S a lo 2u c n 1t u )gt :mo 2en r 3u - 1tA l 4a eJ t -r. i 2mvC 3eo 2oml 1ul .a teb ct oo a mr -a at eni sav .le y Asc ria csr hae In nf do ter r red nve i Mp er w ee ds o .s f 2io 0n 0: 6;166
ColoradoSchoolofMedicineattheAnschutz 3.VaccarinoV,KaslSV,AbramsonJ,KrumholzHM. 15.ChaudhrySI,MatteraJA,CurtisJP,etal.
MedicalCampus,Aurora(Bekelman,Hattler, Depressivesymptomsandriskoffunctionaldecline Telemonitoringinpatientswithheartfailure.NEngl
McBryde,Rumsfeld);Denver-SeattleCenterof anddeathinpatientswithheartfailure.JAmColl JMed.2010;363(24):2301-2309.
InnovationforVeteran-CenteredandValue-Driven Cardiol.2001;38(1):199-205. 16.MorganAL,MasoudiFA,HavranekEP,etal;
Care,Denver,Colorado(Bekelman,Plomondon, 4.RumsfeldJS,HavranekE,MasoudiFA,etal; CardiovascularOutcomesResearchConsortium
Carey,Nelson,Rumsfeld);Departmentof CardiovascularOutcomesResearchConsortium. (CORC).Difficultytakingmedications,depression,
PsychiatryandBehavioralSciences,Universityof Depressivesymptomsarethestrongestpredictors andhealthstatusinheartfailurepatients.JCardFail.
Washington,Seattle(Sullivan);VeteransAffairs ofshort-termdeclinesinhealthstatusinpatients 2006;12(1):54-60.
PugetSoundHealthCareSystem,Seattle, withheartfailure.JAmCollCardiol.2003;42(10): 17.WuJR,LennieTA,DekkerRL,BiddleMJ,Moser
Washington(Nelson,Lehmann);Departmentof 1811-1817. DK.Medicationadherence,depressivesymptoms,
M ( CL ee e nd h tmi ec ri a ,n n Re n i, c)U h;n mRi iv oce h nr m dsi ,t o Vy n io rd gf V iW ne it aa es (rh Gai inn asg nt A oo f ln afa ), ;iS r Cse aa M rt dt el ie d oi lc oa gl
y,
5 A. mK er ru icm anho Hlz eaH rM tA, sC su or cr ii ae tP ioM n, DR ii se eg ae sl eB M,e at na al g;
ement
a hn ed arc ta fr ad ili ua rc ee .v Je Cn at r– dfr Fe ae ils .u 2r 0v 1i 3v ;a 1l 9in (5p ):a 3t 1i 7e -n 3t 2s 4w .ith
VeteransAffairsPaloAltoHealthCareSystem,Palo TaxonomyWritingGroup.Ataxonomyfordisease 18.BekelmanDB,PlomondonME,SullivanMD,
Alto,California(Heidenreich). management:ascientificstatementfromthe etal.Patient-centereddiseasemanagement
AmericanHeartAssociationDiseaseManagement (PCDM)forheartfailure:studyprotocolfora
AuthorContributions:DrsBekelmanand TaxonomyWritingGroup.Circulation.2006;114(13): randomisedcontrolledtrial.BMCCardiovascDisord.
Rumsfeldhadfullaccesstoallthedatainthestudy 1432-1445. 2013;13:49.
andtakeresponsibilityfortheintegrityofthedata
andtheaccuracyofthedataanalysis. 6.FaxonDP,SchwammLH,PasternakRC,etal; 19.GoAS,YangJ,AckersonLM,etal.Hemoglobin
Studyconceptanddesign:Sullivan,Heidenreich, AmericanHeartAssociation’sExpertPanelon level,chronickidneydisease,andtherisksofdeath
Rumsfeld. DiseaseManagement.Improvingqualityofcare andhospitalizationinadultswithchronicheart
Acquisition,analysis,orinterpretationofdata:All throughdiseasemanagement:principlesand failure:theAnemiainChronicHeartFailure:
authors. recommendationsfromtheAmericanHeart OutcomesandResourceUtilization(ANCHOR)
Draftingofthemanuscript:Bekelman. Association’sExpertPanelonDisease Study.Circulation.2006;113(23):2713-2723.
Criticalrevisionofthemanuscriptforimportant Management.Circulation.2004;109(21):2651-2654. 20.BushK,KivlahanDR,McDonellMB,FihnSD,
intellectualcontent:Allauthors. 7.LarameeAS,LevinskySK,SargentJ,RossR, BradleyKA.TheAUDITalcoholconsumption
Statisticalanalysis:Plomondon,Carey. CallasP.Casemanagementinaheterogeneous questions(AUDIT-C):aneffectivebriefscreening
Obtainedfunding:Rumsfeld. congestiveheartfailurepopulation:arandomized testforproblemdrinking:AmbulatoryCareQuality
Administrative,technical,ormaterialsupport: controlledtrial.ArchInternMed.2003;163(7): ImprovementProject(ACQUIP):AlcoholUse
Bekelman,Plomondon,Carey,Lehmann. 809-817. DisordersIdentificationTest.ArchInternMed.
Studysupervision:Bekelman,Sullivan,Hattler, 8.GalbreathAD,KrasuskiRA,SmithB,etal. 1998;158(16):1789-1795.
McBryde,Lehmann,Gianola,Heidenreich, Long-termhealthcareandcostoutcomesofdisease 21.HuntSA,AbrahamWT,ChinMH,etal.2009
Rumsfeld. managementinalarge,randomized, FocusedupdateincorporatedintotheACC/AHA
ConflictofInterestDisclosures:Nonereported. community-basedpopulationwithheartfailure. 2005GuidelinesfortheDiagnosisand
Funding/Support:ThePatient-CenteredHeart Circulation.2004;110(23):3518-3526. ManagementofHeartFailureinAdults:areportof
FailureTrialwasfundedbygrantIIR06-068from 9.DeBuskRF,MillerNH,ParkerKM,etal.Care theAmericanCollegeofCardiology
theDepartmentofVeteransAffairsHealthServices managementforlow-riskpatientswithheart Foundation/AmericanHeartAssociationTaskForce
ResearchandDevelopment.DrBekelmanwas failure:arandomized,controlledtrial.AnnInternMed. onPracticeGuidelines:developedincollaboration
supportedbyCareerDevelopmentAward08-022 2004;141(8):606-613. withtheInternationalSocietyforHeartandLung
f S sr teo urm dv yict .eh se RD ee sp ea ar rt cm he an nt do Df eV ve et le or pa mns eA nf tfa di urs riH ngea thlt ih s 1 m im0 a p. n rS a om g ve eit m mh e eB n n, t tF spo irr nok d pn u ae c tr ie eE s n, lZ ti sma ws il to ie tw hd cqB ou, nae glt it ea y sl -. to iD vf- eis lie hfea es ae
rt
T C 1 .11r 9i 9ra 2c (n u 1 0s 4lp a 6)l t : 5a eio .n 3nt 9a . 1t 2 -i 0 eo 4n 10 7[ 9;p 1 .2u 1b (l 1 di 2s oh ) i:e :e 1d 2 05c .18o 16r ]r . 1e C /cc i irt rci co u un la laa t tp i io op n ne . ha 2r a0s .10i 0n 9 9;
RoleoftheFunder/Sponsor:TheDepartmentof failure:evidencefromarandomizedtrialin
VeteransAffairshadnoroleinthedesignand community-dwellingpatients.AmJManagCare. 22.FihnSD,BucherJB,McDonellM,etal.
conductofthestudy;thecollection,management, 2005;11(11):701-713. Collaborativecareinterventionforstableischemic
a pn rea ply as ri as t, ia on nd ,ri en vte ier wpr ,e ot ra ati po pn ro of vath loe fd ta ht ea; mth ae
nuscript;
1 m1. anY au gD emS, eT nh to pm rop gs ro an mD mR e, sLe foe rD oT ld.D eris pe ea ose
plewith
h 14e 7a 1r -t 14di 7s 9e .ase.ArchInternMed.2011;171(16):
andthedecisiontosubmitthemanuscriptfor heartfailure:crucialcharacteristicswhichimprove 23.UnützerJ,KatonW,CallahanCM,etal;IMPACT
publication. post-dischargeoutcomes.EurHeartJ.2006;27(5): Investigators.Collaborativecaremanagementof
Disclaimer:Theviewsexpressedinthisarticleare 596-612. late-lifedepressionintheprimarycaresetting:
t th ho es pe oo sf itt ioh ne oau rt ph oo lir cs ya on fd thd eo Dno et pn are tc mes es na tr oily freflect 1 m2 a. nR au gm emsf ee nld tJ wS o, rM ksa ,s bo uu td wiF ilA li. tH se ua cr ct ef ea dil ?ur Ee ud rHise eaas rte
J.
(a 2r 2a )n :2d 8o 3m 6iz -2e 8d 4c 5o .ntrolledtrial.JAMA.2002;288
VeteransAffairsortheUSgovernment. 2004;25(18):1565-1567. 24.HeidenreichPA,SpertusJA,JonesPG,etal;
CardiovascularOutcomesResearchConsortium.
Healthstatusidentifiesheartfailureoutpatientsat
jamainternalmedicine.com (Reprinted) JAMAInternalMedicine May2015 Volume175,Number5 731
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Rutgers University Libraries User on 06/01/2015
Research OriginalInvestigation Patient-CenteredDiseaseManagementforHeartFailureTrial
riskforhospitalizationordeath.JAmCollCardiol. 32.WeinbergerM,OddoneEZ,HendersonWG; multidisciplinarycareinheartfailureoutpatientsat
2006;47(4):752-756. VeteransAffairsCooperativeStudyGroupon highriskofhospitalreadmission.JAmCollCardiol.
25.GreenCP,PorterCB,BresnahanDR,SpertusJA. PrimaryCareandHospitalReadmission.Does 2002;39(3):471-480.
DevelopmentandevaluationoftheKansasCity increasedaccesstoprimarycarereducehospital 39.CapomollaS,FeboO,CeresaM,etal.
CardiomyopathyQuestionnaire:anewhealth readmissions?NEnglJMed.1996;334(22): Cost/utilityratioinchronicheartfailure:
statusmeasureforheartfailure.JAmCollCardiol. 1441-1447. comparisonbetweenheartfailuremanagement
2000;35(5):1245-1255. 33.StewartS,PearsonS,HorowitzJD.Effectsofa programdeliveredbyday-hospitalandusualcare.
26.SpertusJ,PetersonE,ConardMW,etal; home-basedinterventionamongpatientswith JAmCollCardiol.2002;40(7):1259-1266.
CardiovascularOutcomesResearchConsortium. congestiveheartfailuredischargedfromacute 40.AtienzaF,AnguitaM,Martinez-AlzamoraN,
Monitoringclinicalchangesinpatientswithheart hospitalcare.ArchInternMed.1998;158(10): etal;PRICEStudyGroup.Multicenterrandomized
failure:acomparisonofmethods.AmHeartJ. 1067-1072. trialofacomprehensivehospitaldischargeand
2005;150(4):707-715. 34.JaarsmaT,HalfensR,HuijerAbu-SaadH,etal. outpatientheartfailuremanagementprogram.Eur
27.KroenkeK,SpitzerRL,WilliamsJB.ThePHQ-9: Effectsofeducationandsupportonself-careand JHeartFail.2004;6(5):643-652.
validityofabriefdepressionseveritymeasure. resourceutilizationinpatientswithheartfailure. 41.MejhertM,KahanT,PerssonH,EdnerM.
JGenInternMed.2001;16(9):606-613. EurHeartJ.1999;20(9):673-682. Limitedlongtermeffectsofamanagement
28.SohnMW,ArnoldN,MaynardC,HynesDM. 35.StewartS,MarleyJE,HorowitzJD.Effectsofa programmeforheartfailure.Heart.2004;90(9):
Accuracyandcompletenessofmortalitydatainthe multidisciplinary,home-basedinterventionon 1010-1015.
DepartmentofVeteransAffairs.PopulHealthMetr. unplannedreadmissionsandsurvivalamong 42.Gwadry-SridharFH,FlintoftV,LeeDS,LeeH,
2006;4:2. patientswithchroniccongestiveheartfailure: GuyattGH.Asystematicreviewandmeta-analysis
2 lo9 n. giL ta ui drd inN alM d, aW taa .r Be ioJ mH e.R tra icn sd .o 19m 8- 2e ;f 3fe 8c (t 4s ):m 9o 6d 3e -9ls 7f 4o .r a (9r 1a 8n 4d )o :1m 0i 7s 7e -d 10co 8n 3t .rolledstudy.Lancet.1999;354 o mf os rt tu ad lii te ys rc ao tem sp inar pin ag tiere na td sm wi is thsio hn ear ra tte fas ila un red
.Arch
36.JerantAF,AzariR,NesbittTS.Reducingthe InternMed.2004;164(21):2315-2320.
3 F i pnr0 ate te. e ierdR v nl ei a tc n snh t wd iM o iK tnW hE t, , coB C opae nrrc genk eveh seya tn im R vt eM tV h h., e eAW arm e rit tat u fe d aln t m ii lb d uie si rs s er c ig .oip NC nl, i EonL nfae gerv y lle d Jn e MrC l eyL d,
.
c h ino e ts a et r rto vf ef a nf ir l tue ioq re nu : .e a Mn rt eah dno d Cs o ap m ri et ia .zl 2ea 0dd 0tm r 1i ;i a 3s ls 9oio (f 1n 1a )s :h 1f o 2o m 3r 4c eo -1tn 2eg 4lee 5cs .ati rv ee 4 A he3 s t. y esG rt oeö gmh el ae ntr eicA ity, mJ oea ftn dau - iz sa ez ni aaJ slL y es, miW s aoo nfr ar te ghl eel mS eS f e, f nie c tt a pa c ryl. oa gn rad
msin
1995;333(18):1190-1195. 37.DoughtyRN,WrightSP,PearlA,etal. congestiveheartfailure.JCardFail.2006;12(7):
Randomized,controlledtrialofintegratedheart 554-567.
31.NaylorM,BrootenD,JonesR,Lavizzo-Mourey failuremanagement:theAucklandHeartFailure
R,MezeyM,PaulyM.Comprehensivedischarge ManagementStudy.EurHeartJ.2002;23(2):
planningforthehospitalizedelderly:arandomized 139-146.
clinicaltrial.AnnInternMed.1994;120(12):
999-1006. 38.KasperEK,GerstenblithG,HefterG,etal.
Arandomizedtrialoftheefficacyof
732 JAMAInternalMedicine May2015 Volume175,Number5 (Reprinted) jamainternalmedicine.com
CCooppyyrriigghhtt 22001155 AAmmeerriiccaann MMeeddiiccaall AAssssoocciiaattiioonn.. AAllll rriigghhttss rreesseerrvveedd..
Downloaded From: http://archinte.jamanetwork.com/ by a Rutgers University Libraries User on 06/01/2015
